Status:
RECRUITING
Performance and Adherence in Children Using Spacers
Lead Sponsor:
University Hospitals of North Midlands NHS Trust
Conditions:
Asthma
Asthma in Children
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
Asthma is a common disease which causes swelling in the airways, making it difficult to breathe. Asthma is common in children, affecting 1 in 11 children in the UK. Asthma is treated with inhalers whi...
Eligibility Criteria
Inclusion
- Aged 6-18 years;
- Attending secondary care with a diagnosis of asthma;
- Willing and able to give fully informed consent, or, participants having an acceptable individual capable of giving consent on the participant's behalf (e.g. parent or guardian of a child under 16 years of age);
- Able to perform lung function and exhaled nitric oxide measurements;
- Take twice-daily preventer medication using a valved holding chamber (spacer device) i.e. inhaled corticosteroid with or without long-acting beta antagonist;
- Willing and able to comply with the study procedures.
Exclusion
- Significant co-existing respiratory disease (e.g. cystic fibrosis);
- Currently participating in another clinical trial of an investigational medicinal product or medical device;
- Non-English speaker where translation facilities are insufficient to guarantee informed consent.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05366309
Start Date
September 1 2022
End Date
December 31 2025
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert James Bowler
Stoke-on-Trent, Staffordshire, United Kingdom, ST44JJ